These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 26300885)

  • 41. Bacterial CD1d-restricted glycolipids induce IL-10 production by human regulatory T cells upon cross-talk with invariant NKT cells.
    Venken K; Decruy T; Aspeslagh S; Van Calenbergh S; Lambrecht BN; Elewaut D
    J Immunol; 2013 Sep; 191(5):2174-83. PubMed ID: 23898038
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.
    Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA
    Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The invariant NKT cell subset in anti-viral defenses: a dark horse in anti-influenza immunity?
    Kulkarni RR; Haeryfar SM; Sharif S
    J Leukoc Biol; 2010 Oct; 88(4):635-43. PubMed ID: 20519638
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system.
    Matsuda JL; Mallevaey T; Scott-Browne J; Gapin L
    Curr Opin Immunol; 2008 Jun; 20(3):358-68. PubMed ID: 18501573
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TCR-mediated recognition of glycolipid CD1 complexes.
    Sullivan BA; Kronenberg M
    Curr Top Microbiol Immunol; 2007; 314():165-93. PubMed ID: 17593661
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Costimulatory activation of murine invariant natural killer T cells by toll-like receptor agonists.
    Kulkarni RR; Villanueva AI; Elawadli I; Jayanth P; Read LR; Haeryfar SM; Sharif S
    Cell Immunol; 2012; 277(1-2):33-43. PubMed ID: 22795895
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The hypervariable region 4 (HV4) and position 93 of the α chain modulate CD1d-glycolipid binding of iNKT TCRs.
    Paletta D; Fichtner AS; Hahn AM; Starick L; Beyersdorf N; Monzon-Casanova E; Mueller TD; Herrmann T
    Eur J Immunol; 2015 Jul; 45(7):2122-33. PubMed ID: 25900449
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Invariant natural killer T (iNKT) cells in asthma: a novel insight into the pathogenesis of asthma and the therapeutic implication of glycolipid ligands for allergic diseases.
    Oki S; Miyake S
    Allergol Int; 2007 Mar; 56(1):7-14. PubMed ID: 17259804
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antigen specificity of invariant natural killer T-cells.
    Birkholz AM; Kronenberg M
    Biomed J; 2015 Dec; 38(6):470-83. PubMed ID: 27013447
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection.
    Brigl M; Tatituri RV; Watts GF; Bhowruth V; Leadbetter EA; Barton N; Cohen NR; Hsu FF; Besra GS; Brenner MB
    J Exp Med; 2011 Jun; 208(6):1163-77. PubMed ID: 21555485
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A humanized mouse model for
    Saavedra-Avila NA; Dellabona P; Casorati G; Veerapen N; Besra GS; Howell AR; Porcelli SA
    Front Immunol; 2022; 13():1011209. PubMed ID: 36263021
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunometabolic Activation of Invariant Natural Killer T Cells.
    Ververs FA; Kalkhoven E; Van't Land B; Boes M; Schipper HS
    Front Immunol; 2018; 9():1192. PubMed ID: 29892305
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interplay between carbohydrate and lipid in recognition of glycolipid antigens by natural killer T cells.
    Pei B; Vela JL; Zajonc D; Kronenberg M
    Ann N Y Acad Sci; 2012 Apr; 1253(1):68-79. PubMed ID: 22352829
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Examining the role of CD1d and natural killer T cells in the development of nephritis in a genetically susceptible lupus model.
    Yang JQ; Wen X; Liu H; Folayan G; Dong X; Zhou M; Van Kaer L; Singh RR
    Arthritis Rheum; 2007 Apr; 56(4):1219-33. PubMed ID: 17393451
    [TBL] [Abstract][Full Text] [Related]  

  • 55. How invariant natural killer T cells respond to infection by recognizing microbial or endogenous lipid antigens.
    Brigl M; Brenner MB
    Semin Immunol; 2010 Apr; 22(2):79-86. PubMed ID: 19948416
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Species Specific Differences of CD1d Oligomer Loading In Vitro.
    Paletta D; Fichtner AS; Starick L; Porcelli SA; Savage PB; Herrmann T
    PLoS One; 2015; 10(11):e0143449. PubMed ID: 26599805
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antigen recognition by CD1d-restricted NKT T cell receptors.
    Godfrey DI; Pellicci DG; Patel O; Kjer-Nielsen L; McCluskey J; Rossjohn J
    Semin Immunol; 2010 Apr; 22(2):61-7. PubMed ID: 19945889
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Different subsets of natural killer T cells may vary in their roles in health and disease.
    Kumar V; Delovitch TL
    Immunology; 2014 Jul; 142(3):321-36. PubMed ID: 24428389
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intestinal microbes affect phenotypes and functions of invariant natural killer T cells in mice.
    Wingender G; Stepniak D; Krebs P; Lin L; McBride S; Wei B; Braun J; Mazmanian SK; Kronenberg M
    Gastroenterology; 2012 Aug; 143(2):418-28. PubMed ID: 22522092
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The fidelity, occasional promiscuity, and versatility of T cell receptor recognition.
    Godfrey DI; Rossjohn J; McCluskey J
    Immunity; 2008 Mar; 28(3):304-14. PubMed ID: 18342005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.